Upcoming Events

AUGMENTED shares the personal journey of Hugh Herr, a double-amputee and MIT scientist who creates brain-controlled robotic limbs. At age 17, Herr’s legs were amputated due to frostbite, after he and a friend got lost in a blizzard and nearly died while climbing New Hampshire’s Mount Washington. Hugh was stunned by the primitive prosthetic legs he was given, and he set out to do something about it. His audacious goal is to eliminate disability, to create a world where designer limbs are as desirable and common as designer eyeglasses. Hugh and Dr. Matthew Carty, a top surgeon at Boston’s Brigham and Women’s Hospital, are creating a radical new way of performing amputations that allows bionic limbs to move and feel like the real thing. Along the way, they just might redefine what it means to be human.

Register now

A scientific breakthrough called CRISPR has given us unprecedented control over the basic building blocks of life. It opens the door to curing diseases, reshaping the biosphere, and designing our own children. HUMAN NATURE is a provocative exploration of CRISPR’s far-reaching implications, through the eyes of the scientists who discovered it, the families it’s affecting, and the bioengineers who are testing its limits. Featuring scientists and writers from Harvard and MIT, we now have the opportunity to see the future, our changing relationship with nature, and how genetic engineering will affect us all.

Register now

SynBioBeta is where tech meets bio and bio meets tech. Meet the innovators and companies, find new opportunities, partner up, and discover the potential of the biological industrial revolution. Join industry influencers October 1-3 in San Francisco to see how synthetic biology is disrupting consumer products, food, agriculture, medicine, chemicals, materials, and more.

Register now

D4 Europe is ram packed full of case studies ⁠— opportunities to get into the weeds, learn, and be inspired. Broken down into two sections (‘Enabling Science’ and ‘Doing Science’), every session has been carefully screened to ensure that data and evidence is presented to back up the incredible work that’s being pioneered within pharma companies. This is a deep-learning environment.
The format is simple. 100 senior technical and scientific leaders in the same room. This is designed to ensure that you leave the event not just armed with new knowledge, but with a renewed list of contacts who you’ve actually had the time to spend time getting to know. Don’t commit to a 1000 person meeting where you learn nothing and get face-time with no-one for longer than two minutes. D4 Europe is a harbour from the storm, where you can spend two highly; productive days in a friendly, welcoming environment where you will meet the right people and develop the right relationships to move your biodata capabilities forward.

Key Benefits of Attending:
• Learn and get inspired from listening to 20+ case studies presenting data, evidence, lessons learned, mistakes, and insights that will drive your own biodata capabilities forward
• Understand and leverage the fast emerging role of the healthcare data ecosystem in transforming drug discovery and development
• Build your biodata capabilities from the bottom up, from both a technical, and scientific standpoint
• Get straight past the hype and vision and into the detail on AI/ML as a tool to build, manage, and examine knowledge and vast data sets
• Spend quality time with other senior level practitioners from Europe’s leading pharma organizations, and leave armed with not just new ideas, but a new support network
This is the most impressive pharma-focused speaker line-up ever assembled for an event on this topic, on a diverse array of subjects tackling THE critical problems in drug development.

Register now

Subscribe to STAT Plus to join STAT senior writer Adam Feuerstein for our next STAT Plus live chat: “The Q4 biotech scorecard.” He’ll answer your burning questions about what this quarter has in store, and take a look at the 13 stock-moving events we’re watching as the year comes to a close.

Register now

The Festival of Biologics combines four outstanding conferences — the European Antibody Congress, the World Immunotherapy Congress, the World Biosimilar Congress, and the Clinical Trials World Congress — to make one amazing event. With both a conference and exhibition, the show brings together industry leaders to meet, discuss, and showcase their work in the biologics, biopharma, and immunotherapy fields, just to name a few. The Congress hosts high-level speakers hailing from big pharma, biotech, academia, regulatory bodies, investor groups, and associations, discussing topics representing key challenges within their industries, new data, case studies, and research.

This year, presentations will move through the entire development pipeline and focus on commercial applications. Join thousands of attendees across the three days to maximize your time with four conferences in one. Discover new innovations and build new business relations on the exhibition floor with solution providers, biotech industry leaders, and world class pharma professionals. Find out about the latest developments in the industry with our Start Up Zone or Poster Display where leading and emerging professionals can exhibit their findings. The Festival of Biologics’ mission is to bring together the full value chains from the antibodies, immunotherapy, clinical trials and biosimilars industries together, located in Basel – a major life science hub.

Register now

D4 USA is ram packed full of case studies – opportunities to get into the weeds, learn, and be inspired. Broken down into two sections (‘Enabling Science’ and ‘Doing Science’), every session has been carefully screened to ensure that data and evidence is presented to back up the incredible work that’s being pioneered within pharma companies. This is a deep-learning environment.
The format is simple. 150 senior technical and scientific leaders in the same room. This is designed to ensure that you leave the event not just armed with new knowledge, but with a renewed list of contacts who you’ve actually had the time to spend time getting to know. Don’t commit to a 1000 person meeting where you learn nothing and get face-time with no-one for longer than two minutes. D4 USA is a harbour from the storm, where you can spend two highly; productive days in a friendly, welcoming environment where you will meet the right people, and develop the right relationships to move your biodata capabilities forward.

Key Benefits of Attending:

• Learn and get inspired from listening to 30+ case studies presenting data, evidence, lessons learned, mistakes, and insights that will drive your own biodata capabilities forward
• Understand and leverage the fast emerging role of the healthcare data ecosystem in transforming drug discovery and development
• Build your biodata capabilities from the bottom up, from both a technical and scientific standpoint
• Get straight past the hype and vision and into the detail on AI/ML as a tool to build, manage, and examine knowledge and vast data sets
• Meet and spend time with other senior-level pharma and biotech leaders from pioneering organizations

This is the most impressive pharma-focused speaker line-up ever assembled for an event on this topic, on a diverse array of subjects tackling THE critical problems in drug development.

Register now

Learn about U.S. government medical countermeasure priorities (and funding opportunities) by attending BARDA Industry Day 2019 via livestream at M2D2.

Register now

Subscribe to STAT Plus to join STAT senior writer Adam Feuerstein for our next STAT Plus live chat: “The Q4 biotech scorecard.” He’ll answer your burning questions about what this quarter has in store, and take a look at the 13 stock-moving events we’re watching as the year comes to a close.

Register now